Download full report with analyst certification and important disclosures
Aug 27 2024, 08:40 IST/BST
Malin previously reported that its intrinsic value at June 30th was €6.44/share. It has confirmed this in its H1 results today and also announced that its intrinsic value was €6.33/share at August 22nd. The company has also confirmed that the tender offer post the sale of its stake in CG Oncology will be for €45m and requires approval at an EGM.
Aug 27 2024, 08:40 IST/BST